LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    Germany: Industrial Bioeconomy Dialogue Platform of the Federal Ministry for Economic Affairs and Energy (BMWE), Position paper on amending the European GMO legal framework for microorganisms.

    23/01/2026

    POLICY DOCUMENT

    Germany, October 2025 – Industrial Bioeconomy Dialogue Platform of the Federal Ministry for Economic Affairs and Energy (BMWE), Position paper on amending the European GMO legal framework for microorganisms.

    This position paper, prepared by the Industrial Bioeconomy Dialogue Platform under the German Federal Ministry for Economic Affairs and Energy, outlines key challenges and opportunities within the current EU regulatory system for genetically modified microorganisms.

    The current EU framework governing genetically modified organisms (GMOs) and, in particular, genetically modified microorganisms (GMMs) pose major challenges for companies seeking approval for innovative products and production processes. New genomic techniques such as the Nobel Prize‑winning CRISPR/Cas technology offer enormous potential for biotechnology as a key technology for a future‑oriented, climate‑neutral and sustainable economy.

    This position paper presents an evidence‑ and knowledge‑based proposal for redesigning the EU GMO legal framework for microorganisms. Its central recommendation is to move away from the current process‑based approach towards a product‑based framework that better reflects scientific progress and supports innovation while maintaining high safety standards.

    Source: Industrial Bioeconomy Dialogue Platform of the Federal Ministry for Economic Affairs and Energy (BMWE)

    Position paper on amending the European GMO legal framework for microorganisms. Industrial Bioeconomy Dialogue Platform of the Federal Ministry for Economic Affairs and Energy (BMWE)


    Download

    Summary: Position paper on amending the European GMO legal framework for microorganisms. Industrial Bioeconomy Dialogue Platform of the Federal Ministry for Economic Affairs and Energy (BMWE)


    Download
    Share
    Communications Team
    Communications Team

    Related posts

    22/01/2026

    BIOTECH AUSTRIA joins EuropaBio: Fostering Austrian Biotech Collaboration


    Read more
    13/01/2026

    Response to the EC Call for Evidence on the Advanced Materials Act


    Read more
    19/12/2025

    Ribbon Bio GmbH joins EuropaBio: Redefining Scientific Possibility through Synthetic DNA Innovation


    Read more

    Important links

    • Germany: Industrial Bioeconomy Dialogue Platform of the Federal Ministry for Economic Affairs and Energy (BMWE), Position paper on amending the European GMO legal framework for microorganisms.
    • BIOTECH AUSTRIA joins EuropaBio: Fostering Austrian Biotech Collaboration

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.